Latest Breaking News On - Nate liabraaten - Page 1 : comparemela.com

Verastem Oncology Reports Second Quarter 2023 Financial Results and Highlights Recent Company Progre

Presented Positive Results from Part A of RAMP 201 Trial of Avutometinib and Defactinib in Recurrent Low-Grade Serous Ovarian Cancer (LGSOC) at American Society of Clinical Oncology MeetingEstablished Design for RAMP 301 Phase 3 Confirmatory Trial of Avutometinib and Defactinib in Recurrent LGSOCStrengthened Balance.

United statesDan calkinsKarin tollefsonDan patersonRobert gagnonBrian stuglikElisa buffingtonNate liabraatenCompany board of directorsRaf and mek programCommercialization committeeAmerican society of clinical oncology meetingCorporate communicationsCompany phaseEuropean network of gynaecological oncological trialExchange commission

Verastem Oncology Announces Design for Confirmatory Trial of Avutometinib and Defactinib in Recurren

Randomized Phase 3 Trial (RAMP 301) Will Evaluate the Combination of Avutometinib and Defactinib vs Standard of Care Treatment; Study to Commence in 2H 2023Recently Published Data from Part A of RAMP 201 Trial Show an Objective Response Rate of 45%, and Manageable Safety and Tolerability Profile with the Combination.

United statesCity ofUnited kingdomDan calkinsElisa buffingtonBrian stuglikNate liabraatenRachel grishamSusana banerjeeNational cancer instituteInstitute of cancer researchEuropean society of gynaecological oncologyPartners programCorporate communicationsChugai pharmaceutical co ltdDrug administration

Verastem Oncology Announces Design for Confirmatory Trial of Avutometinib and Defactinib in Recurrent Low-Grade Serous Ovarian Cancer

Verastem Oncology Announces Design for Confirmatory Trial of Avutometinib and Defactinib in Recurrent Low-Grade Serous Ovarian Cancer
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesCity ofUnited kingdomBrian stuglikRachel grishamNate liabraatenDan calkinsElisa buffingtonSusana banerjeeChugai pharmaceutical co ltdNational cancer instituteEuropean network for gynaecological oncological trialRaf and mek programEuropean network of gynaecological oncological trialInstitute of cancer researchCompany intends to file for accelerated

Verastem Oncology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Verastem Oncology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesNate liabraatenElisa buffingtonDan calkinsCantor fitzgerald coCapital marketsExchange commissionVerastem oncologyEquity capital marketsCantor fitzgeraldAnnual report

Verastem Oncology (VSTM) Appoints Karin Tollefson to its Board

Verastem Oncology (VSTM) Appoints Karin Tollefson to its Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

University of kansasUnited statesEli lillyNate liabraatenKarin tollefsonMichael kauffmanElisa buffingtonDan calkinsRaf and mek programExchange commissionChugai pharmaceutical co ltdLymphoma society indiana board of trusteesKansas state universityDrug administrationAmerican lung associationImclone systems